Last updated on November 2017

SYNERGY


Brief description of study

SYNERGY

Detailed Study Description

A Randomized, Double-Blind, Parallel-Group, Placebo- and Active-Controlled, Multi-center Study to Evaluate the Efficacy, Safety and Tolerability of Combinations of Solifenacin Succinate and Mirabegron Compared to Solifenacin Succinate and Mirabegron Monotherapy in the Treatment of Overactive Bladder

Clinical Study Identifier: TX81369

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Christina Wegerski

Urology Group of New Mexico
Albuquerque, NM USA
  Connect »